{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T22:01:06Z","timestamp":1779400866071,"version":"3.53.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.euo.2025.01.008","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T16:23:24Z","timestamp":1739809404000},"page":"1260-1266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Are Patients with Prostate Imaging Reporting and Data System 5 Lesions Eligible for Active Surveillance? A Multicentric European Study"],"prefix":"10.1016","volume":"8","author":[{"given":"Arthur","family":"Peyrottes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baboudjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Diamand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Ducrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Vitard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Baudewyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Windisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Anract","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Dariane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Tricard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Sarkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvanne","family":"Sadreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Oderda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut Long","family":"Depaquit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre De","family":"La Taille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Brureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Rouviere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Crouzet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Ruffion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Desgrandchamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Roumiguie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Ploussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaelle","family":"Fiard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.01.008_b0005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors\u2014a systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.008_b0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging \u2013 reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"issue":"76","key":"10.1016\/j.euo.2025.01.008_b0015","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2","volume":"2019","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.008_b0020","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.01.008_b0025","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/pros.24280","article-title":"Preoperative MRI PI\u2010RADS scores are associated with prostate cancer upstaging on surgical pathology","volume":"82","author":"Pockros","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2025.01.008_b0030","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/JU.0000000000001307","article-title":"PI-RADS\u00ae category as a predictor of progression to unfavorable risk prostate cancer in men on active surveillance","volume":"204","author":"Wang","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.01.008_b0035","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00345-023-04371-6","article-title":"Prognostic significance of PI-RADS 5 lesions in patients treated by radical prostatectomy","volume":"41","author":"Fiard","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.01.008_b0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.008_b0045","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.eururo.2019.09.020","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel consensus statements for deferred treatment with curative intent for localised prostate cancer from an international collaborative study (DETECTIVE study)","volume":"76","author":"Lam","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.01.008_b0050","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. ed. 8. Wiley Blackwell; 2016. p. 272. Union for International Cancer Control (UICC). https:\/\/www.uicc.org\/resources\/tnm-classification-malignant-tumours-8th-edition."},{"key":"10.1016\/j.euo.2025.01.008_b0055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.euo.2022.09.005","article-title":"Magnetic resonance imaging\u2013based T-staging to predict biochemical recurrence after radical prostatectomy: a step towards the iTNM classification","volume":"6","author":"Baboudjian","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.01.008_b0060","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2025.01.008_b0065","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2025.01.008_b0070","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1200\/JCO.2015.62.5764","article-title":"Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer","volume":"33","author":"Tosoian","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2025.01.008_b0075","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/JU.0000000000001903","article-title":"Factors associated with discontinuation of active surveillance among men with low-risk prostate cancer: a population-based study","volume":"206","author":"Timilshina","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.01.008_b0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.euf.2019.05.011","article-title":"Outcomes of serial multiparametric magnetic resonance imaging and subsequent biopsy in men with low-risk prostate cancer managed with active surveillance","volume":"7","author":"Hsiang","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.01.008_b0085","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.euo.2020.12.004","article-title":"Positive predictive value of Prostate Imaging Reporting and Data System version 2 for the detection of clinically significant prostate cancer: a systematic review and meta-analysis","volume":"4","author":"Mazzone","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.01.008_b0090","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00428-020-02858-w","article-title":"Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading","volume":"477","author":"Egevad","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.euo.2025.01.008_b0095","doi-asserted-by":"crossref","first-page":"781.e1","DOI":"10.1016\/j.urolonc.2021.01.008","article-title":"Comparison of initial and second opinion reads of multiparametric magnetic resonance imaging of the prostate for transperineal template-guided biopsies with MRI-ultrasound fusion","volume":"39","author":"Ecke","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.01.008_b0100","doi-asserted-by":"crossref","first-page":"793.e13","DOI":"10.1016\/j.urolonc.2020.03.015","article-title":"Effects of \u201creal life\u201d prostate MRI inter-observer variability on total needle samples and indication for biopsy","volume":"38","author":"Rosenzweig","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.01.008_b0105","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1007\/s00261-021-03023-w","article-title":"Assessment of prostate imaging reporting and data system version 2.1 false-positive category 4 and 5 lesions in clinically significant prostate cancer","volume":"46","author":"Wang","year":"2021","journal-title":"Abdom Radiol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:34:00Z","timestamp":1766511240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125000240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2588931125000240"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.01.008","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are Patients with Prostate Imaging Reporting and Data System 5 Lesions Eligible for Active Surveillance? A Multicentric European Study","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}